In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies
- PMID: 37754311
- PMCID: PMC10529770
- DOI: 10.3390/diseases11030115
In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies
Abstract
Alpha synuclein (α-Syn) is a neuronal protein encoded by the SNCA gene and is involved in the development of Parkinson's disease (PD). The objective of this study was to examine in silico the functional implications of non-synonymous single nucleotide polymorphisms (nsSNPs) in the SNCA gene. We used a range of computational algorithms such as sequence conservation, structural analysis, physicochemical properties, and machine learning. The sequence of the SNCA gene was analyzed, resulting in the mapping of 42,272 SNPs that are classified into different functional categories. A total of 177 nsSNPs were identified within the coding region; there were 20 variants that may influence the α-Syn protein structure and function. This identification was made by employing different analytical tools including SIFT, PolyPhen2, Mut-pred, SNAP2, PANTHER, PhD-SNP, SNP&Go, MUpro, Cosurf, I-Mut, and HOPE. Three mutations, V82A, K80E, and E46K, were selected for further examinations due to their spatial positioning within the α-Syn as determined by PyMol. Results indicated that these mutations may affect the stability and function of α-Syn. Then, a molecular dynamics simulation was conducted for the SNCA wildtype and the four mutant variants (p.A18G, p.V82A, p.K80E, and p.E46K). The simulation examined temperature, pressure, density, root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), and radius of gyration (Rg). The data indicate that the mutations p.V82A, p.K80E, and p.E46K reduce the stability and functionality of α-Syn. These findings highlight the importance of understanding the impact of nsSNPs on α-syn structure and function. Our results required verifications in further protein functional and case-control studies. After being verified these findings can be used in genetic testing for the early diagnosis of PD, the evaluation of the risk factors, and therapeutic approaches.
Keywords: Parkinson’s disease (PD); SNCA gene non-synonymous single nucleotide polymorphisms (nsSNPs); alpha-synuclein (α-Syn) protein; bioinformatics; synucleinopathies.
Conflict of interest statement
The authors declare that no conflict of interest exist.
Figures









Similar articles
-
In Silico Investigation of AKT2 Gene and Protein Abnormalities Reveals Potential Association with Insulin Resistance and Type 2 Diabetes.Curr Issues Mol Biol. 2023 Sep 12;45(9):7449-7475. doi: 10.3390/cimb45090471. Curr Issues Mol Biol. 2023. PMID: 37754255 Free PMC article.
-
Impact of nonsynonymous single nucleotide polymorphisms in PROCR gene on protein stability and thrombotic risk: a molecular dynamic approach.Front Genet. 2025 Apr 30;16:1580993. doi: 10.3389/fgene.2025.1580993. eCollection 2025. Front Genet. 2025. PMID: 40370698 Free PMC article.
-
Prediction and assessment of deleterious and disease causing nonsynonymous single nucleotide polymorphisms (nsSNPs) in human FOXP4 gene: An in - silico study.Heliyon. 2024 Jun 15;10(12):e32791. doi: 10.1016/j.heliyon.2024.e32791. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 38994097 Free PMC article.
-
α-Synuclein in Parkinson's disease: causal or bystander?J Neural Transm (Vienna). 2019 Jul;126(7):815-840. doi: 10.1007/s00702-019-02025-9. Epub 2019 Jun 25. J Neural Transm (Vienna). 2019. PMID: 31240402 Review.
-
An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.Mol Neurobiol. 2022 Jan;59(1):620-642. doi: 10.1007/s12035-021-02596-3. Epub 2021 Nov 8. Mol Neurobiol. 2022. PMID: 34750787 Review.
Cited by
-
Computational prediction of the pathogenic variants of arachidonate 5-lipoxygenase activating protein using Molecular Dynamics simulation.PLoS One. 2025 Jul 30;20(7):e0329126. doi: 10.1371/journal.pone.0329126. eCollection 2025. PLoS One. 2025. PMID: 40737279 Free PMC article.
References
-
- Calabresi P., Mechelli A., Natale G., Volpicelli-Daley L., Di Lazzaro G., Ghiglieri V. Alpha-synuclein in Parkinson’s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14:176. doi: 10.1038/s41419-023-05672-9. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous